Impact of the Temporal Relationship Between Atrial Fibrillation and Heart Failure on Prognosis After Ablation.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 08 2020
Historique:
pubmed: 21 7 2020
medline: 14 10 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.Methods and Results:We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25-4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942-5.5; P<0.0001). Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.

Sections du résumé

BACKGROUND
The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.Methods and Results:We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25-4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942-5.5; P<0.0001).
CONCLUSIONS
Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.

Identifiants

pubmed: 32684540
doi: 10.1253/circj.CJ-20-0191
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1467-1474

Commentaires et corrections

Type : CommentIn

Auteurs

Aki Tsuji (A)

Division of Internal Medicine, Moriguchi Keijinkai Hospital.

Masaharu Masuda (M)

Kansai Rosai Hospital Cardiovascular Center.

Mitsutoshi Asai (M)

Kansai Rosai Hospital Cardiovascular Center.

Osamu Iida (O)

Kansai Rosai Hospital Cardiovascular Center.

Shin Okamoto (S)

Kansai Rosai Hospital Cardiovascular Center.

Takayuki Ishihara (T)

Kansai Rosai Hospital Cardiovascular Center.

Kiyonori Nanto (K)

Kansai Rosai Hospital Cardiovascular Center.

Takashi Kanda (T)

Kansai Rosai Hospital Cardiovascular Center.

Takuya Tsujimura (T)

Kansai Rosai Hospital Cardiovascular Center.

Yasuhiro Matsuda (Y)

Kansai Rosai Hospital Cardiovascular Center.

Shota Okuno (S)

Kansai Rosai Hospital Cardiovascular Center.

Yosuke Hata (Y)

Kansai Rosai Hospital Cardiovascular Center.

Toshiaki Mano (T)

Kansai Rosai Hospital Cardiovascular Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH